Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Portugal Contract Awarded For 2023/0304 - Treprostinilo [200 Mg; Sol Inj; Frs] treprostinilo [200 Mg; Sol Inj; Frs] value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :23/01/2025 estimated Value Excluding Vat :.2023/0304 - Treprost 2025-11-19
Portugal Contract Awarded For 2024/0900- Elvitegravir + Cobicistate + Emitricitabine + Tenofovir Alafenamida [150 + 150 + 200 +10 Mg; Cáp/comp] elvitegravir + Cobicistate + Emtricitabine + Tenofovir Alafenamida [150 + 150 + 200 +10 Mg; Cáp/comp] value Of The Resul 2025-11-19
Portugal Contract Awarded For 2023/0491 - Leupro -survender [45 Mg; Powder And Solv For Sol Inj; Syringe] leupro -application [45 Mg; Powder And Solv For Sol Inj; Syringe] value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :06/01/2 2025-11-19
Portugal Contract Awarded For 2023/0491 - Leupro -survender [45 Mg; Powder And Solv For Sol Inj; Syringe] leupro -application [45 Mg; Powder And Solv For Sol Inj; Syringe] value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :17/03/2 2025-11-19
Portugal Contract Awarded For 2023/0491- Darolutamida [300 Mg; Cable/compensation] darolutamida [300 Mg; Cable/compensation] value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :20/02/2025 estimated Value Excluding Vat :.2023/0491- 2025-11-19
Portugal Contract Awarded For 2023/0491 - Immunoglobulin Antilinfocytes (rabbit) [25 Mg; P/ Conc Powder P/ A Sol P/ Perf; Frs] immunoglobulin Anti -lymphocytes (rabbit) [25 Mg; P/ Conc Powder P/ A Sol P/ Perf; Frs] value Of The Result: winner Selection Date : 2025-11-19
Portugal Contract Awarded For 2023/0491- Ibrutinib [140 Mg; Cable/compensation] ibrutinib [140 Mg; Cable/compensation] value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :23/01/2025 estimated Value Excluding Vat :.2023/0491- Ibruti 2025-11-19
Portugal Contract Awarded For 2023/0491- Baricitinib [4 Mg; Cáp/ Comp] baricitinib [4 Mg; Cáp/ Comp] value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :23/01/2025 estimated Value Excluding Vat :.2023/0491- Baricitinib [4 Mg; Cáp/ 2025-11-19
Portugal Contract Awarded For 2022/0058- Agalsidase Beta [35 Mg; F/amp] agalsidase Beta [35 Mg; F/amp] value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :08/01/2025 estimated Value Excluding Vat :.2022/0058- Agalsidase Beta [35 Mg 2025-11-19
Portugal Contract Awarded For 2023/0491 - Pertuzumab [420 Mg/14 Ml; Sol Inj; Frs] pertuzumab [420 Mg/14 Ml; Sol Inj; Frs] value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :16/01/2025 estimated Value Excluding Vat :.2023/0491 - Pe 2025-11-19
Whats app